All updated as on -
By 2030, the market for life science reagents is anticipated to reach USD 69,384 million, growing at an estimated CAGR of 8.9% from 2023 to 2030. The market for life science reagents has expanded as a result of the rise in life science research institutes.
Life science reagents are essential to the pharmaceutical, biotechnology, life science, and healthcare industries. The global market for life science reagents is predicted to expand rapidly during the forecast period as a result of the rise in the usage of in vitro diagnostics for the diagnosis of several chronic and infectious diseases. A treatment's design and effectiveness evaluation can both be done using reagents from the life sciences. It is anticipated that governments and private businesses will expand their financing for pharmaceutical R&D, assisting in the creation of new products and technologies.
A few factors driving market expansion include the rise in infectious diseases as well as technological advancements in the biotechnology and life sciences sectors. The widespread incidence of infectious diseases is due to viruses, parasites, and other dangerous microorganisms. These diseases can be transmitted directly or indirectly from one person to another. They are highly contagious and readily spread if precautions are not done. Due to a lack of healthcare infrastructure and resources, these diseases can be lethal in many developed and underdeveloped countries. According to a CDC research from February 2022, the salmonella bacteria are expected to be responsible for about 1.35 million infections, 26,500 hospitalisations, and 420 fatalities each year in the United States.An abundance of contagious illnesses strain the nation's healthcare system each year. As a result, there is a greater than ever requirement for diagnostic tools, which will increase market demand.
The rising incidence of infectious diseases like Zika, Dengue, and HIV has a direct impact on the increased need for life science reagents. In 2019, there were 34,800 new HIV infections at a rate of 12.6; this equates to over 1.2 million people living with the illness in the United States (per 100,000 people), according to information made public by HIV.gov in June 2021. This indicates that there is a high prevalence of HIV in the nation, which will increase demand for its diagnostic goods and drive the market.
Report Coverage
Global Life Science Reagents research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Life Science Reagents report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Life Science Reagents competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Life Science Reagents market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Life Science Reagents market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Life Science Reagents market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Agilent Technologies, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc, QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments plc, and Zeiss International
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Life Science Reagents market based on the below-mentioned segments:
Global Life Science Reagents Market, By By Product Type
Global Life Science Reagents Market, By End User
Global Life Science Reagents market, Regional Analysis
Life science reagents are essential to the pharmaceutical, biotechnology, life science, and healthcare industries. The global market for life science reagents is predicted to expand rapidly during the forecast period as a result of the rise in the usage of in vitro diagnostics for the diagnosis of several chronic and infectious diseases. A treatment's design and effectiveness evaluation can both be done using reagents from the life sciences. It is anticipated that governments and private businesses will expand their financing for pharmaceutical R&D, assisting in the creation of new products and technologies.
A few factors driving market expansion include the rise in infectious diseases as well as technological advancements in the biotechnology and life sciences sectors. The widespread incidence of infectious diseases is due to viruses, parasites, and other dangerous microorganisms. These diseases can be transmitted directly or indirectly from one person to another. They are highly contagious and readily spread if precautions are not done. Due to a lack of healthcare infrastructure and resources, these diseases can be lethal in many developed and underdeveloped countries. According to a CDC research from February 2022, the salmonella bacteria are expected to be responsible for about 1.35 million infections, 26,500 hospitalisations, and 420 fatalities each year in the United States.An abundance of contagious illnesses strain the nation's healthcare system each year. As a result, there is a greater than ever requirement for diagnostic tools, which will increase market demand.
The rising incidence of infectious diseases like Zika, Dengue, and HIV has a direct impact on the increased need for life science reagents. In 2019, there were 34,800 new HIV infections at a rate of 12.6; this equates to over 1.2 million people living with the illness in the United States (per 100,000 people), according to information made public by HIV.gov in June 2021. This indicates that there is a high prevalence of HIV in the nation, which will increase demand for its diagnostic goods and drive the market.
Report Coverage
Global Life Science Reagents research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Life Science Reagents report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Life Science Reagents competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Life Science Reagents market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Agilent Technologies, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc, QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments plc, and Zeiss International |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Life Science Reagents Market from 2021 to 2030.
- Market Forecast for Life Science Reagents Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Life Science Reagents competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Life Science Reagents
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Life Science Reagents market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Life Science Reagents market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Agilent Technologies, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc, QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments plc, and Zeiss International
Primary Target Market
- Market Players of Life Science Reagents
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Life Science Reagents market based on the below-mentioned segments:
Global Life Science Reagents Market, By By Product Type
- Cell and Tissue Culture Reagents
- Chromatography Reagents
- Clinical Chemistry Reagents
- Immunoassay Reagents
- Molecular Diagnostic Reagents
- Microbiology Reagents
- Other Product Types
Global Life Science Reagents Market, By End User
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Other End Users
Global Life Science Reagents market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive life science reagents market market research and competitor analysis for your business to help you develop more profound insights into the life science reagents market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the life science reagents market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.